远程缺血预适应在血管外科中的系统综述与荟萃分析
结果显示RIPC对死亡率、肾功能不全、心肌梗死、心肌损伤或住院时间均无显著改善,当前证据不支持RIPC在血管外科中的常规应用。
要点
- RIPC对血管外科患者死亡率、肾功能不全、心肌梗死等结局无显著获益。
- 亚组和敏感性分析均未显示RIPC的显著效应。
- 建议开展更大规模多中心试验进一步验证RIPC在重大血管手术中的作用。
核心结论
- 当前证据表明RIPC在血管外科中无获益。
研究设计与样本
- 系统综述与荟萃分析,纳入13项随机对照试验,RIPC组548例,对照组549例。
主要发现
- RIPC组与对照组在死亡率、肾功能不全、心肌梗死、心肌损伤或住院时间上均无显著差异,亚组和敏感性分析亦无显著差异。
临床怎么用
- 基于当前证据,RIPC不应作为血管外科患者的常规干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remote ischemic preconditioning (RIPC) is a method of preparing the body for a later prolonged ischemic episode to protect against subsequent detrimental effects. This study aimed to identify the effects of RIPC in vascular surgery. METHODS: A standard Preferred Reporting Items for Systematic Reviews and Meta-Analyses search was conducted of randomized controlled trials of RIPC in patients undergoing open or endovascular aneurysm repair, carotid endarterectomy, or lower limb bypass reporting on mortality and renal or cardiac outcomes. Random-effects meta-analysis was performed using Review Manager 5.3 (The Nordic Cochrane Center, Copenhagen, Denmark). RESULTS: A total of 13 randomized controlled trials in the meta-analysis included 548 patients in the RIPC cohort and 549 controls. There was no significant difference in mortality, renal dysfunction, myocardial infarction, myocardial injury, or length of stay between the groups, with subgroup and sensitivity analysis showing no significant difference. CONCLUSIONS: Current evidence demonstrates no benefit of RIPC in vascular surgery. Further large multicenter trials of RIPC in major vascular surgery should be considered.
引用
- Stather PW, Wych J, Boyle JR, et al. A systematic review and meta-analysis of remote ischemic preconditioning for vascular surgery. J Vasc Surg. 2019. PMID: 31401109. doi:10.1016/j.jvs.2019.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。